Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
83.007,99
-3,65%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ovid Therapeutics Inc (OVID) Ovid Therapeutics Inc (OVID) Notizie

Ovid Therapeutics Inc

OVID
0,5796
0,061 (11,76%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202522:08EDGAR2Form 8-K - Current report
03/3/202514:00GLOBEOvid Therapeutics Appoints Pioneering Industry Leader Dr...
28/2/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202514:00GLOBEOvid Therapeutics to Present at the TD Cowen 45th Annual..
25/2/202501:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202523:41EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/2/202523:15EDGAR2Form 8-K - Current report
05/2/202514:00GLOBEOvid Therapeutics to Present at the Oppenheimer 35th Annual..
29/1/202515:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202414:00GLOBEOvid Therapeutics to Present Multiple Posters Supporting Its..
12/11/202414:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:03EDGAR2Form 8-K - Current report
12/11/202414:00GLOBEOvid Therapeutics Reports Business Updates and Third Quarter..
31/10/202413:00GLOBEOvid Therapeutics to Host Investor Event
26/9/202414:00GLOBEOvid Therapeutics Presents Pre-Clinical Study Results..
11/9/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202423:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/9/202422:57EDGAR2Form 8-K - Current report
11/9/202414:00GLOBEMeg Alexander Takes on Expanded Role as President and COO at..
04/9/202414:00GLOBEOvid Therapeutics to Present at Upcoming September Investor..
13/8/202414:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:02EDGAR2Form 8-K - Current report
13/8/202414:00GLOBEOvid Therapeutics Reports Business Updates and Second..
08/8/202414:00GLOBEOvid Therapeutics Appoints Dr. Amanda Banks, Experienced..
02/8/202423:22EDGAR2Form 8-K - Current report
30/7/202414:00GLOBEOvid Therapeutics to Present at Upcoming August Investor..
23/7/202414:00GLOBEOvid Therapeutics Expands Scientific Advisory Board with..
10/7/202414:00GLOBEeNeuro Publishes Findings on the Anti-Convulsant Properties..
01/7/202414:00GLOBEOvid Therapeutics and Graviton Bioscience Announce Topline..
17/6/202413:10EDGAR2Form 8-K - Current report
17/6/202412:55GLOBEOvid Therapeutics Reports on Takeda’s Announcement of Phase..
07/6/202422:22EDGAR2Form 8-K - Current report
14/5/202423:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/5/202414:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202414:03EDGAR2Form 8-K - Current report
14/5/202414:00GLOBEOvid Therapeutics Reports Business Updates and First Quarter..
13/5/202413:00GLOBEOvid Therapeutics to Present at the H.C. Wainwright 2nd..
04/4/202414:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
Apertura: 0,506 Min: 0,506 Max: 0,5381
Chiusura: 0,5186

La tua Cronologia

NASDAQ
OVID
Ovid Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci